rent-now

Rent More, Save More! Use code: ECRENTAL

5% off 1 book, 7% off 2 books, 10% off 3+ books

9780521711005

The BMT Data Book

by
  • ISBN13:

    9780521711005

  • ISBN10:

    0521711002

  • Edition: 2nd
  • Format: Paperback
  • Copyright: 2009-03-23
  • Publisher: Cambridge University Press
  • Purchase Benefits
  • Free Shipping Icon Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • eCampus.com Logo Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $105.00

Summary

The BMT Data Book is an essential guide to the data, outcome studies and complex decision-making processes involved in blood and marrow stem cell transplantation. Organized according to types of diseases and procedures, it contains more than hundred tables, figures and algorithms that reflect up-to-date research and give guidance on the choices between stem cell versus bone marrow transplantation, autologous versus allogeneic transplantation, and conventional versus experimental treatments. This new edition summarizes research of the last 5 years and gives mature data for all established indications, such as acute myeloid leukemia, myelodysplastic syndromes, Hodgkin's and Non-Hodgkin's lymphomas. In addition, controversies and new indications - like renal cell cancer and autoimmune disorders - are discussed plus new drugs and therapies, new stem cell sources (cord blood), new transplant protocols (reduced-intensity conditioning), and a guide to electronic databases.

Author Biography

Reinhold Munker is Associate Professor of Medicine, Department of Medicine, Division of Hematology/Oncology, Louisiana State University Health Sciences Center, USA. Hillard M. Lazarus is Professor of Medicine, Case Western Reserve University, and Director, Blood and Marrow Transplant Program, University Hospitals Case Medical Center, USA. Kerry Atkinson is Professor of Medicine, University of Queensland; Director of Allogeneic Stem Cell Therapies; Director, Mater Health Services Cell Therapy Quality Management System; and Head, Biotherapy Program, Mater Medical Research Institute, Mater Adult Hospital, Australia.

Table of Contents

List of contributorsp. ix
Forewordp. xi
Prefacep. xiii
Acknowledgmentsp. xvi
Basic sciencep. 1
Basic sciencep. 3
Hematologic malignanciesp. 21
Therapeutic decision making in BMT/SCT for acute myeloid leukemiap. 23
Therapeutic decision making in BMT/SCT for acute lymphoblastic leukemiap. 41
Therapeutic decision making in BMT/SCT for chronic myeloid leukemia and other myeloproliferative syndromesp. 57
Therapeutic decision making in BMT/SCT for chronic lymphatic leukemiap. 71
Therapeutic decision making in BMT/SCT for myelodysplasiap. 85
Therapeutic decision making in BMT/SCT for non-Hodgkin Lymphomap. 99
Therapeutic decision making in BMT/SCT for Hodgkin lymphomap. 127
Therapeutic decision making in hematopoietic stem cell transplantation for multiple myelomap. 139
Therapeutic decision making in BMT/SCT for amyloidosisp. 157
Solid tumorsp. 163
Therapeutic decision making in stem cell transplantation for breast cancerp. 165
Therapeutic decision making in BMT/SCT for nonseminomatous germ cell tumor of testis (NSGCT)p. 169
Therapeutic decision making in BMT/SCT for renal cell cancerp. 177
Therapeutic decision making in BMT/SCT for soft tissue sarcomasp. 189
Nonmalignant disordersp. 195
Therapeutic decision making in BMT/SCT for severe aplastic anemiap. 197
Therapeutic decision making in BMT/SCT for congenital immunodeficienciesp. 205
Therapeutic decision making in BMT/SCT for hemoglobinopathiesp. 215
Therapeutic decision making in BMT/SCT for autoimmune disordersp. 227
Practical aspects and proceduresp. 233
Practical aspects and procedures, including conditioning protocols and haploidentical transplantationp. 235
Umbilical cord blood as alternative allogeneic graft source: clinical banking and transplant outcomesp. 301
Complicationsp. 311
Pathobiology of graft-versus-host diseasep. 313
Diagnosis and treatment of graft-versus-host-diseasep. 331
Management and prophylaxis of infections after BMT/SCTp. 357
Organ-related and miscellaneous complicationsp. 379
The BMT/SCT pharmacopoeiap. 429
The BMT/SCT pharmacopoeiap. 431
HLA-testing and laboratory medicinep. 493
HLA-testing and laboratory medicinep. 495
Appendixp. 511
Indexp. 515
Table of Contents provided by Ingram. All Rights Reserved.

Supplemental Materials

What is included with this book?

The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.

The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.

Rewards Program